Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
about
Molecular signatures of proliferation and quiescence in hematopoietic stem cellsComputer aided analysis of additional chromosome aberrations in Philadelphia chromosome positive acute lymphoblastic leukaemia using a simplified computer readable cytogenetic notationThe Philadelphia chromosome in leukemogenesisNew Developments in Chronic Myeloid Leukemia: Implications for TherapyAcute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative NeoplasmsKinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitorsAcute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literatureZebrafish Models of Human Leukemia: Technological Advances and Mechanistic InsightsChronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responsesBCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death thresholdTargeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia.CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data.Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.EVI1 activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22).A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasSNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.A novel t(9;22;11) translocation involving 11q24 in a patient with chronic myeloid leukemia: A case report.BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP.Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia.Unusual T-lymphoblastic blast phase of chronic myelogenous leukemiaThe breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeatsChronic myeloid leukemia: mechanisms of blastic transformationMechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia.Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cellsThe JAK2 exon 12 mutations: a comprehensive review.Shattered and stitched chromosomes-chromothripsis and chromoanasynthesis-manifestations of a new chromosome crisis?Identification of genes potentially involved in disease transformation of CML.Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.The dynamics of cancer chromosomes and genomes.Myc roles in hematopoiesis and leukemiaDuplication of Subcytoband 11E2 of Chromosome 11 Is Regularly Associated with Accelerated Tumor Development in v-abl/myc-Induced Mouse Plasmacytomas.CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways.High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia.Advances in targeted therapy for chronic myeloid leukemia.The occurrence of Philadelphia chromosome (Ph) negative leukemia after hematopoietic stem cell transplantation for Ph positive chronic myeloid leukemia: implications for disease monitoring and treatment.Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cellsCentrosome aberrations--hen or egg in cancer initiation and progression?
P2860
Q24795386-A0F6E7C2-475C-4E3B-9DE6-0F6ACEC2F7BFQ24798120-FB64D5D3-FE8C-497B-955C-50E1F7B9B4D4Q26745531-35B4B6F7-C516-48A0-9DCD-E49F733C528EQ26745669-C5F8C3E0-8BCA-4919-B1BA-FE1AB9781D79Q26799790-478EC777-9B38-4C92-8F0F-E1D540621D03Q26849792-00706959-8B70-4DB3-B5DE-C6041EE94DFAQ28073281-22BA6455-026B-4348-9837-805CE4297AFAQ28078210-DBDA2403-889F-4BAD-B8CC-19C355E21A6BQ28475717-BE87B770-B4BA-489A-AA28-7B3D40433B7DQ28704493-E08CD3B9-8F7F-404F-94EB-A1EADBD522D6Q30010486-029CD5AD-5956-4B97-9B6D-E163F2F91942Q30677391-ED2659B1-F8D6-438F-A91E-AD0499E769D4Q33213461-2B536AD2-D699-4194-9058-952BE8ADCB4FQ33350395-6DBDB4A5-8A10-4B6E-9207-FB44D4DE2506Q33411250-00E273F7-27AD-42AF-A845-DC45DABB9B61Q33517413-7EA6289F-14BF-4254-904F-0BC69FB166BCQ33518973-CF648698-E818-49A2-8FC4-723B30E06BE4Q33524890-ED94A823-11D1-4F78-B80D-820AB5D64272Q33597612-A336D4D1-9461-4B32-B5C2-A93545E00499Q33727572-37194F0C-6C89-4B05-9609-45AF5A35010AQ33809446-687413E6-9783-44C9-B0CE-B540FE667714Q33892579-A54423C3-2CFE-4DF3-B501-8F60E98913B4Q33909470-E5D97AF4-CA63-4A50-AF32-4616C0D95CF9Q33968037-47D355E8-16B1-4A68-AB7F-D3F6EE92B8FFQ34016866-DAB9274B-369C-4D27-BD89-AFAC92E410E1Q34024223-D4042C84-BC48-452D-B004-3355B990E475Q34192739-6B8D035D-C02C-4059-8D87-7995431F5B29Q34289009-FDE9F0C4-1B14-4801-817B-9100E5E9A412Q34409580-A7BC0C90-97FA-479E-B0D1-81EF7573BDADQ34508425-2805F101-4DC4-4C32-8EC5-6D2943F21E34Q34713402-2B4B3CD4-9C9B-446A-A4EF-B1CD9573D4B1Q34972364-4350F685-D373-44B6-8FC9-E770CF7C4B39Q34972481-E35A541A-98ED-4066-83CC-DCA71AED079FQ35030952-1CF8963D-04C7-43A1-8426-4D271DFF010EQ35102301-9809DFC6-6C23-4836-9AB0-954A9B66B7D6Q35104353-1D921DDE-4A69-4819-95ED-D2A75694E507Q35160190-03848219-C4CE-43E1-A4F1-586706C96557Q35198916-A0E4C27B-AC93-40A9-A813-AA6BEBAAD863Q35847760-786CD0AE-BC1E-43D6-9B1B-EDB94B367B74Q36109658-074BA9FF-4C2C-493B-9FD0-E985EA43BA23
P2860
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@ast
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@en
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@nl
type
label
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@ast
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@en
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@nl
prefLabel
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@ast
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@en
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
@nl
P356
P1433
P1476
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia
@en
P2093
Bertil Johansson
Felix Mitelman
P356
10.1159/000046636
P577
2002-01-01T00:00:00Z